Michael Cloonan Insider Trading
Get free email notifications about insider trading for Michael Cloonan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Cloonan. Michael Cloonan is a Chief Business Officer in Sage Therapeutics, Inc. ($SAGE).
Address: C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE 02142 MA
Companies in which Michael Cloonan is an Insider
Sage Therapeutics, Inc.
Trading Symbol: SAGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Cloonan: Chief Business Officer
Holdings: 3,190 shares
Current Value: $152,163
Latest Transaction: May 05 2020
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael Cloonan
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2020 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 37.13 | 50,000 | 1,856,500 | 50,000 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Payment of Exercise | F | 161.38 | 1,088 | 175,581 | 2,102 | 3.2 K to 2.1 K (-34.11 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Grant | A | 0.00 | 2,450 | 0 | 3,190 | 740 to 3.2 K (+331.08 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | M | 73.43 | 25,000 | 1,835,750 | 160,000 | |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Sell | S | 175.00 | 25,000 | 4,375,000 | 461 | 25.5 K to 461 (-98.19 %) |